Risk of cognitive impairment in men with advanced prostate cancer treated with NHAs: A systematic review and network meta‐analysis

Novel hormonal agents (NHAs) have significantly improved outcomes in men with advanced prostate cancer. However, it remains unclear whether NHAs are associated with subsequent cognitive impairment. Thus, we sought to perform a network meta‐analysis to compare the risk of cognitive impairment across...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Shi‐Wei, Chen, Li‐Chin, Tseng, Chi‐Shin, Chen, Chung‐Hsin, Yuan, Lun‐Hsiang, Shau, Wen‐Yi, Pu, Yeong‐Shiau
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9926078/
https://www.ncbi.nlm.nih.gov/pubmed/36369801
http://dx.doi.org/10.1111/cts.13451

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9926078/
https://www.ncbi.nlm.nih.gov/pubmed/36369801
http://dx.doi.org/10.1111/cts.13451

Ejemplares similares